Cellex
Device Critical Care
PDI 20705030300000
General payments
$438,382
Research payments
$546,190
Through program year 2024, $438,382 in general payments and $546,190 in research payments were reported against Cellex (Critical Care).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $171,880 | 56 |
| 2024 | Research | $157,000 | 4 |
| 2023 | General | $116,188 | 59 |
| 2023 | Research | $255,532 | 5 |
| 2022 | Research | $78,000 | 1 |
| 2021 | General | $150,314 | 4 |
| 2021 | Research | $55,658 | 1 |
Breakdown
The top 5 of 27 recipients; each share is of general payments naming this product in 2024.
The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 13 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
119 general · 11 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.